 
<ichicsr lang="en">
	<ichicsrmessageheader>
		<messagetype>ICSR</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>1.0</messageformatrelease>
		<messagenumb>6</messagenumb>
		<messagesenderidentifier>EMEO5</messagesenderidentifier>
		<messagereceiveridentifier>Egyptian PV</messagereceiveridentifier>
		<messagedateformat>102</messagedateformat>
		<messagedate>20160506 </messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1.0</safetyreportversion>
		
		<!--A.1.0.1 Sender’s (case) safety report unique identifier-->
		<safetyreportid> EG-EMEO5-6</safetyreportid>
		
		<!--     A.1.1 Identification of the country of the primary source -->
		<primarysourcecountry>EG</primarysourcecountry>
		
		<!--      A.1.3 Date of this transmission -->
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20160506 </transmissiondate>
		
		<!--     A.1.4 Type of report --> 
		<reporttype>spontaneous</reporttype>
 		
 		<!--A.1.5 Seriousness -->
 		<serious>yes</serious>
		
		<!--A.1.5.2. Seriousness criteria-->
		<seriousnessdeath>yes</seriousnessdeath>
		<seriousnesslifethreatening>yes</seriousnesslifethreatening>
		<seriousnesshospitalization>yes</seriousnesshospitalization>
		<seriousnessdisabling>yes</seriousnessdisabling>
		<seriousnesscongenitalanomali>yes</seriousnesscongenitalanomali>
		<seriousnessother>yes</seriousnessother>
		
		<!--*** A.1.6 Date report was first received from source-->
		<receivedateformat>102</receivedateformat>
		<receivedate>19970102</receivedate>
        
        <!--*** A.1.7	Date of receipt of the most recent information for this report --> 
        <receiptdateformat>102</receiptdateformat>
		<receiptdate>20160506 </receiptdate>
		
		<!--A.1.10	Worldwide unique case identification number.      --> 
		<companynumb> EG-EMEO5-6</companynumb>
 
					<primarysource>
				<!--A.2.1.1	Reporter identifier (name or initials)       -->
				<reportergivename>sdfs</reportergivename>
				<reporterfamilyname>dfasdfas</reporterfamilyname>
				
				<!-- A.2.1.2	Reporter’s address          -->
				<reporterstreet>fasdfsa dfasdfas </reporterstreet>
				<reportercity>dfasdfasd</reportercity>
				<reporterstate>fasdfsaf</reporterstate>
				<reporterpostcode>sdfas</reporterpostcode>
			
				<!--  A.2.1.3	Country           -->
				<reportercountry>EG</reportercountry>
				
				<!-- A.2.1.4	Qualification           -->
				<qualification> Lawyer </qualification>

			</primarysource>  
	 
		 
	
	<!-- A.3	Sender	and reviver          -->
		<sender>
 			
<!-- A.3.1.1	Sender Type          -->
			<sendertype>pharmaceutical company</sendertype>
					
<!--	A.3.1.2	Sender identifier          -->
			<senderorganization>EMEO5</senderorganization>

<!--***	A.3.1.3	Person responsible for sending the report      -->
			<sendergivename>ahmed</sendergivename>

<!-- A.3.1.4l E-mail address -->
 			<senderemailaddress>ahmed@ahmed.com</senderemailaddress>

 		</sender>
 

		<receiver>
			 <!--	A.3.2.1	Receiver Type          -->
			<receivertype>Regulatory authority</receivertype>
		</receiver>

		<patient>
<!--  B.1.1	Patient (name or initials)        -->
			<patientinitial>as </patientinitial>

<!--  B.1.2.1	Date of birth         -->
			<patientbirthdateformat>102</patientbirthdateformat>
            <patientbirthdate>0002-12-02</patientbirthdate>
<!--  B.1.2.2	Age at time of onset of reaction / event   -->
			<patientonsetage>1.00</patientonsetage>
			<patientonsetageunit>week</patientonsetageunit>
<!--  B.1.3	Weight (kg)          -->
			<patientweight>1.00</patientweight>

<!--  B.1.7.2	Text for relevant medical history and concurrent conditions (not including reaction/event) -->
			<patientmedicalhistorytext>11</patientmedicalhistorytext>

				<reaction>
<!--  B.2.i.0	Reaction or event as reported by the primary source   -->
				<primarysourcereaction>dgdfg</primarysourcereaction>

<!--  B.2.i.1	Reaction or event in MedDRA terminology (Lowest Level Term)   -->
				<reactionmeddraversionllt> v. 2.3 </reactionmeddraversionllt>
				<reactionmeddrallt>LkpMeddraLlt 2222</reactionmeddrallt>
<!--  B.2.i.2	Reaction or event in MedDRA terminology (Preferred Term)    -->
				<reactionmeddraversionpt>  v. 2.3 </reactionmeddraversionpt>
				<reactionmeddrapt>LkpMeddraPt1-2</reactionmeddrapt>
<!--  B.2.i.4	Date of start of reaction or event     -->
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>2016-03-30</reactionstartdate>
<!--  B.2.i.5	Date of end of reaction or event     -->
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>2016-05-10</reactionenddate>

<!--  B.2.i.8	Outcome of reaction or event at the time of last observation (Recovered/resolved,Recovering/resolving,Not-->
				<reactionoutcome>Recovered/resolved</reactionoutcome>


			</reaction>
	

			<test>
			<!--B.3.1	Structured information (repeat as necessary)       -->
				<testdateformat>102</testdateformat>
				<testdate>2016-03-30</testdate>
				<testname>	blood presure</testname>
				<testresult>xcx</testresult>
				<testunit>fgdfg</testunit>
				<lowtestrange>sdfgsdfg</lowtestrange>
				<hightestrange>sdfgdfs</hightestrange>
				<moreinformation>dsgffd</moreinformation>
			
		</test>
					<drug>
<!--  B.4.k.1	Characterization of drug role (Suspect/Concomitant/Interacting)    -->   
				<drugcharacterization></drugcharacterization>

<!--  B.4.k.2	Drug identification           -->

 
				<medicinalproduct>vitac</medicinalproduct>

				 <!--  B.4.k.3	Batch/lot number           -->
				<drugbatchnumb>sdf</drugbatchnumb>

<!--  B.4.k.6	Dosage text           -->
				<drugdosagetext>dfgdf</drugdosagetext>

<!--  B.4.k.8	Route of administration   -->       
				<drugadministrationroute>11</drugadministrationroute>

<!--  B.4.k.11	Indication for use in the case       -->
				<drugindication></drugindication>
<!--  B.4.k.12	Date of start of drug        -->
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2016-03-30</drugstartdate>
<!--  B.4.k.14	Date of last administration      -->  
 				<drugenddateformat>102</drugenddateformat>
				<drugenddate></drugenddate>
<!--  B.4.k.15	Duration of drug administration      -->   
				<drugtreatmentduration></drugtreatmentduration>
				<drugtreatmentdurationunit>day</drugtreatmentdurationunit>
<!--  B.4.k.16	Action(s) taken with drug (− Drug withdrawn,− Dose reduced,− Dose increased,− Dose -->
 
				
<!--  B.4.k.17	Effect of rechallenge          -->
				<drugrecurreadministration>yes</drugrecurreadministration>

<!--  B.4.k.19	Additional information on drug     -->    
				<drugadditional></drugadditional>
			</drug>
	
 		</patient>
	</safetyreport>
</ichicsr>
